InnoCare Pharma Ltd 9969.HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 05/17/24 CTT
5.10quote price arrow up+0.11 (+2.20%)
Volume
7,981,000
52 week range
4.03 - 9.44
Loading...
  • Open4.99
  • Day High5.28
  • Day Low4.99
  • Prev Close4.99
  • 52 Week High9.44
  • 52 Week High Date05/16/23
  • 52 Week Low4.03
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap25.58M
  • Shares Out15.34M
  • 10 Day Average Volume4.1M
  • Dividend-
  • Dividend Yield-
  • Beta0.3
  • YTD % Change-25.98

KEY STATS

  • Open4.99
  • Day High5.28
  • Day Low4.99
  • Prev Close4.99
  • 52 Week High9.44
  • 52 Week High Date05/16/23
  • 52 Week Low4.03
  • 52 Week Low Date04/19/24
  • Market Cap25.58M
  • Shares Out15.34M
  • 10 Day Average Volume4.1M
  • Dividend-
  • Dividend Yield-
  • Beta0.3
  • YTD % Change-25.98

RATIOS/PROFITABILITY

  • EPS (TTM)-0.58
  • P/E (TTM)-8.76
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On InnoCare Pharma Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with large unmet clinical needs, such as oncology and autoimmune diseases. The Company's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat...
Jisong Cui Ph.D.
Executive Chairman of the Board, Chief Executive Officer
Nan Gao
Chief Operation Officer
Shaojing Tong
Chief Financial Officer
Xiangyang Chen
Chief Technology Officer
Address
Building 8, No. 8
Life Science Park Road, Zhongguancun
Life Science Park, Changping District
Beijing, BEJ
102206
China